| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.00035 | 1 |